Orphion Therapeutics, Inc. — Form D
Orphion Therapeutics, Inc. of GREAT NECK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2020-11-17. The offering totals $16.3M, of which $5.3M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2020-11-17
- Form: D
- Accession: 0001832539-20-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $16.3M
- Amount sold: $5.3M
- Remaining: $11.0M
- Investors: 4
- Date of first sale: 2020-11-10
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-380761
Issuer
- Name: Orphion Therapeutics, Inc.
- CIK: 0001832539
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 57 MEADOW WOODS ROAD, GREAT NECK, NY, 11020
- Phone: 9179515659
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Michael Mashaal | Director | Great River, NY |
| Jason Slakter | Director | Great Neck, NY |
| Nickolay Voronin | Director | Great Neck, NY |
| Jason Slakter | Executive Officer | Great Neck, NY |
More